| Vol. 16.04 – 1 February, 2024 |
| |
|
|
| Scientists identified mismatch repair gene, MLH1 as a genetic interactor of BRCA2 whose over-expression supported the viability of Brca2-null cells. Mechanistically, they showed that MLH1 interactd with Flap endonuclease 1 and competed to process the RNA flaps of Okazaki fragments. [Journal Of Clinical Investigation] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| The authors introduced a one-shot injectable nano-in-gel vaccine (NIGel-Vax) for postoperative breast cancer therapy. The NIGel-Vax was constructed by mixing protein antigens with PEI-4BImi-Man adjuvant and then encapsulated in a hydrogel made with oxidized dextran and 4-arm PEG-ONH2. [ACS Nano] |
|
|
|
| Investigators discovered that EMSY, inducing a BRCAness phenotype, was preferentially expressed in breast CSCs, promoted ALDH+ cells enrichment, and was positively correlated with poor relapse-free survival. [Cell Reports Medicine] |
|
|
|
| Researchers demonstrated a novel role for LBH in promoting TNBC cell survival. Depletion of LBH in multiple TNBC cell models triggered apoptotic cell death both in vitro and in vivo and led to S-G2M cell cycle delays. [Oncogene] |
|
|
|
| Investigators found that lncRNA DLEU2 and ROR1 were specifically upregulated in tumor tissues compared to their normal counterparts in TCGA, PubMed GEO datasets, and samples from archived breast cancer tumor tissues. [Cell Death Discovery] |
|
|
|
| The authors elucidated the possible anticancer potential of four compounds 7, 4′, 7′′, 4′′′-tetra-O-methyl amentoflavone, hesperidin, ferulic acid, and chlorogenic acid that are isolated from Cycas thouarsii leaves n-butanol fraction for the first time. [Artificial Cells Nanomedicine And Biotechnology] |
|
|
|
| Scientists investigated the expression of Del-1 and maternal embryonic leucine zipper kinase (MELK), mRNA levels in eight different TNBC cell lines were analyzed. [Breast Cancer Research And Treatment] |
|
|
|
| Researchers found that propranolol significantly reduced lung metastasis in 4T1 murine breast cancer cells. In vitro and in vivo experiments demonstrated that propranolol inhibited the epithelial–mesenchymal transition as evidenced by Western Blot analysis. [Journal Of Cancer Research And Clinical Oncology] |
|
|
|
| The authors probed if the transcription factor CTCF plays a role in the differential expression of ESR1 in the breast cancer cell lines MCF-7 and MDA-MB-231. [Molecular Biology Reports] |
|
|
|
|
| Scientists provide a comprehensive overview of the characteristics of breast cancer metastases, shedding light on the pivotal roles of immune and resident cells in the development of distinct metastatic foci. [Cell Communication And Signaling] |
|
|
|
| Investigators summarize the regulatory mechanisms of RNA-binding proteins (RBPs) and their signaling crosstalk in breast cancer. They emphasize the potential of certain RBPs as prognostic factors due to their effects on proliferation, invasion, apoptosis, and therapy resistance of breast cancer cells. [Critical Reviews In Oncology/Hematology] |
|
|
|
|
| With the development of the first-in-class fatty acid synthase inhibitor denifanstat, which is being evaluated in a Phase II trial, investigators are hoping that the agent can be a key component in restoring sensitivity to standard treatments for patients with HER2- positive metastatic breast cancer. [OncLive] |
|
|
|
|
| March 21 – 23, 2024 Tokyo, Japan |
|
|
|
|
|
| National Cancer Institute – Bethesda, Maryland, United States |
|
|
|
| University of Nottingham – Nottingham, England, United Kingdom |
|
|
|
| Karolinska Institutet – Solna, Sweden |
|
|
|
| University of Birmingham – Birmingham, England, United Kingdom |
|
|
|
| Princeton University – Princeton, New Jersey, United States |
|
|
|
|